Stokes Bio

The company also said it expects continued growth in this area due in part to the introduction later this year of microfluidics-based PCR technology obtained through last year's acquisition of Stokes Bio.

Startups QuantaLife and Inostics join more established outfits RainDance Technologies and Life Technologies in exploring the digital PCR market, but all players will need to negotiate what is sure to be a complex intellectual property landscape.

Digital PCR may be on the verge of becoming nearly as ubiquitous as its predecessor, quantitative real-time PCR, thanks to the integration of empowering nanoscale and microfluidic technologies.

Life Tech officials said that Stokes Bio's microfluidics-based technology platform will enable high-throughput, PCR-based genetic analyses for a variety of applications, particularly in the area of agricultural biology.

In Brief This Week is a Friday column containing news items that our readers may have missed during the week.

Chinese state news agency Xinhua reports that a preliminary investigation has found He Jiankui performed his gene-editing work illegally.

John Mendelsohn, a former president of the University of Texas MD Anderson Cancer Center, has died, the New York Times reports.

Identical twins receive different estimates of ancestry from the same direct-to-consumer genetic testing firms, CBC reports.

In PNAS this week: chromosomal features of maize, adaptations in the vinous-throated parrotbill, and more.